Associated Papers
Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches.
Ng J et al.
Cells, 2023
The dopamine transporter gene SLC6A3: multidisease risks.
Reith MEA et al.
Molecular Psychiatry, 2022
Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.
Sutton C et al.
Frontiers in Cellular Neuroscience, 2022
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
Bhat S et al.
Pharmacology & Therapeutics, 2021
Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters.
Bhat S et al.
Acs Pharmacology & Translational Science, 2021
Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.
Heidari E et al.
Annals of Human Genetics, 2020
Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS.
Reith MEA et al.
Bioorganic & Medicinal Chemistry Letters, 2018
SLC6 Transporter Folding Diseases and Pharmacochaperoning.
Freissmuth M et al.
Handbook of Experimental Pharmacology, 2018
Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
Ng J et al.
Brain : a Journal of Neurology, 2014
Select a paper to view details